Liquidia Corp (NASDAQ:LQDA) Adds 0.07 Percent In A Week: What Motivates The Stock?

In last trading session, Liquidia Corp (NASDAQ:LQDA) saw 1.64 million shares changing hands with its beta currently measuring 0.03. Company’s recent per share price level of $13.6 trading at -$0.18 or -1.31% at ring of the bell on the day assigns it a market valuation of $1.16B. That closing price of LQDA’s stock is at a discount of -42.72% from its 52-week high price of $19.41 and is indicating a premium of 39.26% from its 52-week low price of $8.26.

For Liquidia Corp (LQDA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Liquidia Corp (NASDAQ:LQDA) trade information

Upright in the red during last session for losing -1.31%, in the last five days LQDA remained trading in the green while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $13.6 price level, adding 1.66% to its value on the day. Liquidia Corp’s shares saw a change of 11.48% in year-to-date performance and have moved 0.07% in past 5-day. Liquidia Corp (NASDAQ:LQDA) showed a performance of -11.40% in past 30-days.

Wall Street analysts have assigned a consensus price target of 19 to the stock, which implies a rise of 28.42% to its current value. Analysts have been projecting 13 as a low price target for the stock while placing it at a high target of 36. It follows that stock’s current price would jump 4.41% in reaching the projected high whereas dropping to the targeted low would mean a gain of 4.41% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 8.44% during past 5 years.

Liquidia Corp (NASDAQ:LQDA)’s Major holders

CALIGAN PARTNERS LP is the top institutional holder at LQDA for having 10.36 million shares of worth $124.33 million. And as of 2024-06-30, it was holding 13.5551 of the company’s outstanding shares.

The second largest institutional holder is PATIENT SQUARE CAPITAL LP, which was holding about 7.18 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.3968 of outstanding shares, having a total worth of $86.19 million.